The Latest News from VIGH

VIGH to partner with Yale University and University of Liberia on New Research and Teaching Center in Liberia

The Vanderbilt Institute of Global Health (VIGH) will join Yale University and the University of Liberia College of Health Sciences (ULCHS) to establish a public-private-academic hub for research utilization in the Liberian health sector and an academic network to strengthen Liberia’s education and health sectors as part of a five-year, $15 million federal project announced this week.

NIH Training Grant Enhances Research Administration in Nigeria

In continuing, longstanding research collaborations between the Aminu Kano Teaching Hospital (AKTH) and Bayero University Kano (BUK) in Kano, Nigeria, and the Vanderbilt Institute for Global Health (VIGH), the three institutions are partnering on a new Infrastructure Development Training Program from the Fogarty International Center of the National Institutes of Health (NIH). The project will strengthen infrastructure capacity in research administration and research ethics in Nigeria.

Vanderbilt Researchers Receive Grant to Reinforce Institutional Capacity for the Conduct of Research at University Eduardo Mondlane (UEM) in Mozambique

Working in collaboration with faculty from UEM, the Vanderbilt Institute for Global Health (VIGH) will work to build UEM’s institutional research capacity with support from the NIH Fogarty International Center (FIC).

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique. One of the $1.5 million grants will establish The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program to build capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.